1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Anta L, Blanco JL, Llibre JM, García F, Pérez-Elías MJ, Aguilera A, Pérez-Romero P, Caballero E, Vidal C, Cañizares A, Gutiérrez F, Dalmau D, Iribarren JA, Soriano V, de Mendoza C.

    Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    The Journal of antimicrobial chemotherapy . 68(9): 1994-2002. Nº de citas: 9

    [doi:10.1093/jac/dkt146]

  • Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O.

    Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

    PLOS MEDICINE . 10(9): . Nº de citas: 228

    [doi:10.1371/journal.pmed.1001510]

  • Castronuovo D, Cacopardo B, Pinzone MR, Di Rosa M, Martellotta F, Schioppa O, Moreno S, Nunnari G.

    Bone disease in the setting of HIV infection: update and review of the literature

    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES . 17(18): 2413-2419. Nº de citas: 34

  • Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.

    Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials

    AIDS . 27(13): 2081-2088. Nº de citas: 13

    [doi:10.1097/QAD.0b013e328361d0e1]

  • Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.

    All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

    BMC INFECTIOUS DISEASES . 13: 382-382. Nº de citas: 18

    [doi:10.1186/1471-2334-13-382]

  • Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.

    Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections

    CLINICAL INFECTIOUS DISEASES . 57(3): 458-464. Nº de citas: 3

    [doi:10.1093/cid/cit221]

  • Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.

    Travel associated Diseases, Indian Ocean Islands, 1997-2010

    EMERGING INFECTIOUS DISEASES . 19(8): 1297-1301. Nº de citas: 17

    [doi:10.3201/eid1908.121739]

  • Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.

    Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

    CLINICAL AND VACCINE IMMUNOLOGY . 20(8): 1197-1202. Nº de citas: 17

    [doi:10.1128/CVI.00221-13]

  • Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R.

    Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment

    ACTA TROPICA . 127(2): 101-104. Nº de citas: 28

    [doi:10.1016/j.actatropica.2013.04.003]

  • Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.

    The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients

    NEPHROLOGY DIALYSIS TRANSPLANTATION . 28(8): 2073-2081. Nº de citas: 17

    [doi:10.1093/ndt/gft210]

  • Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.

    Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.

    AIDS . 27(11): 1771-1778. Nº de citas: 105

    [doi:10.1097/QAD.0b013e3283612419]

  • Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H, BENCHMRK Study Teams.

    Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.

    LANCET INFECTIOUS DISEASES . 13(7): 587-596. Nº de citas: 103

    [doi:10.1016/S1473-3099(13)70093-8]

  • Casado JL.

    Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine

    AIDS REVIEWS . 15(3): 139-145. Nº de citas: 14

  • Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA.

    Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies

    AIDS . 27(10): 1641-1655. Nº de citas: 6

    [doi:10.1097/QAD.0b013e3283601199]

  • Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA.

    The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

    AIDS . 27(9): 1513-1516. Nº de citas: 107

    [doi:10.1097/QAD.0b013e32835faa72]

  • Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, Cantón R, Meseguer MA.

    Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 32(6): 769-772. Nº de citas: 46

    [doi:10.1007/s10096-012-1805-5]

  • Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J.

    Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

    JOURNAL OF HEPATOLOGY . 58(6): 1104-1112. Nº de citas: 22

    [doi:10.1016/j.jhep.2013.01.042]

  • Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M.

    Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia

    The Journal of antimicrobial chemotherapy . 68(6): 1423-1430. Nº de citas: 38

    [doi:10.1093/jac/dkt016]